drugset / Trial / NCT01998685

Prothrombotic Factors and Anaesthesia in Prostate Cancer

NCT01998685 ↗

Completed 200 enrolled Regina Elena Cancer Institute
Non-randomizedParallel-groupDouble-blindPrevention

Summary

This study aims to assess if different anesthetic techniques can affect coagulant factors in patients with prostate cancer undergoing elective laparoscopic radical prostatectomy (LRP).

Timeline

Start
2013-06
Primary completion
2013-12
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Background Fentanyl Other / unclassified 1.5 ug/kg —
Background Midazolam Small molecule 0.1 mg/kg —
Comparator Propofol Small molecule 4 ug/ml Intravenous
Comparator Remifentanil Small molecule 0.25 ug/kg Intravenous
Background Sevoflurane Other / unclassified 2 % Inhaled

Indications